The isoquinolinone-based tetracyclic compounds were designed and synthesized and their PARP-1 inhibitory activity was evaluated. Most of synthesized compounds showed fairly good activity. Also the most active compound 6 showed its activity on potentiation of anticancer agents, temozolamide and etoposide, by 1.7 times, respectively.
设计并合成了基于
异喹啉酮的四环化合物,并评估了其对PARP-1的抑制活性。大多数合成的化合物显示出相当好的活性。活性最高的化合物6也显示出其对抗癌药
替莫唑胺和
依托泊苷的增强作用,分别是其1.7倍。